医药股全线爆发!辉瑞60亿押注中国抗癌药

华尔街见闻
20 May

辉瑞斥资60亿美元押注中国抗癌药研发,带动中国医药股持续飙升。 20日周二,生物医药股爆发,港股恒生生物科技指数大涨超4%,板块内三生制药(3SBio)超35%,荣昌生物涨14%,瀚森制药、石药集团等纷纷走高。宁德时代在港交所上市首日涨近17%。 华尔街见闻此前提及,辉瑞与中国沈阳的三生制药达成协议,就PD-1/VEGF双特异性抗体SSGJ-707达成首付12.5亿美元,总额60.5亿美元的全球...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10